Camillo Aliberti

2.5k total citations
71 papers, 1.7k citations indexed

About

Camillo Aliberti is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Camillo Aliberti has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 31 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Camillo Aliberti's work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Camillo Aliberti is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Camillo Aliberti collaborates with scholars based in Italy, United States and United Kingdom. Camillo Aliberti's co-authors include Giammaria Fiorentini, Giorgio Benea, Massimo Tilli, Francesca Montagnani, Luca Mulazzani, Gina Turrisi, Andrea Mambrini, Paolo Coschiera, Vincenzo Catalano and Donatella Sarti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Camillo Aliberti

67 papers receiving 1.7k citations

Peers

Camillo Aliberti
S Zangos Germany
Camillo Aliberti
Citations per year, relative to Camillo Aliberti Camillo Aliberti (= 1×) peers S Zangos

Countries citing papers authored by Camillo Aliberti

Since Specialization
Citations

This map shows the geographic impact of Camillo Aliberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camillo Aliberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camillo Aliberti more than expected).

Fields of papers citing papers by Camillo Aliberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camillo Aliberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camillo Aliberti. The network helps show where Camillo Aliberti may publish in the future.

Co-authorship network of co-authors of Camillo Aliberti

This figure shows the co-authorship network connecting the top 25 collaborators of Camillo Aliberti. A scholar is included among the top collaborators of Camillo Aliberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camillo Aliberti. Camillo Aliberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavalletto, Luisa, Eleonora Bertoli, Claudia Mescoli, et al.. (2025). Long-Term Risk of Hepatic and Extrahepatic-Related Events After Direct Antiviral Therapy for Chronic Hepatitis C: A Prospective Long-Term Study Cohort. Cancers. 17(9). 1528–1528.
2.
Delogu, Angelica Bibiana, Camillo Aliberti, Gabriella De Rosa, et al.. (2024). Autonomic cardiac function in children and adolescents with long COVID: a case-controlled study. European Journal of Pediatrics. 183(5). 2375–2382. 10 indexed citations
3.
Aliberti, Camillo, Harmony Impellizzeri, Marco Inama, et al.. (2023). Microwave ablation for large benign thyroid nodules: a proposal for a new approach: “the fluid-motion technique”. Updates in Surgery. 76(1). 239–244. 1 indexed citations
4.
Fiorentini, Giammaria, Donatella Sarti, M Nardella, et al.. (2021). Transarterial Chemoembolization Alone or Followed by Bevacizumab for Treatment of Colorectal Liver Metastases. SHILAP Revista de lepidopterología. 9(1). HEP40–HEP40. 3 indexed citations
5.
Pelizzaro, Filippo, Romilda Cardin, Camillo Aliberti, et al.. (2021). Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines. 9(8). 890–890. 18 indexed citations
6.
Fiorentini, Giammaria, Donatella Sarti, Roberto Nani, et al.. (2020). Updates of colorectal cancer liver metastases therapy: review on DEBIRI. SHILAP Revista de lepidopterología. 7(1). HEP16–HEP16. 29 indexed citations
7.
Pelizzaro, Filippo, Romilda Cardin, Camillo Aliberti, et al.. (2020). Scca-Igm in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization: Gender-Related Differences. Biomarkers in Medicine. 14(10). 855–867. 4 indexed citations
8.
Tropea, Saveria, Simone Mocellin, Giovanni Damiani, et al.. (2020). Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors. European Journal of Surgical Oncology. 47(5). 1201–1206. 12 indexed citations
9.
Fiorentini, Giammaria, et al.. (2018). Chemoembolization in Conjunction with Bevacizumab: Preliminary Results. Journal of Vascular and Interventional Radiology. 29(9). 1236–1239. 4 indexed citations
10.
Guadagni, Stefano, Giammaria Fiorentini, Marco Clementi, et al.. (2017). Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?. International Journal of Molecular Sciences. 18(11). 2382–2382. 8 indexed citations
11.
Aliberti, Camillo, Sara Lonardi, Vincenzo Dadduzio, et al.. (2017). Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center. Journal of Vascular and Interventional Radiology. 28(11). 1495–1502. 43 indexed citations
12.
Fiorentini, Giammaria, Donatella Sarti, Luca Mulazzani, et al.. (2016). Hepatic arterial infusion of Polythylene Glycol drug-eluting beads for Primary liver cancer therapy. Annals of Oncology. 27. iv24–iv24. 2 indexed citations
13.
Nicoletto, Maria Ornella, Alessandra Baldoni, Eliana Rulli, et al.. (2016). Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy. Anticancer Research. 36(12). 6541–6546. 2 indexed citations
14.
15.
Indraccolo, Stefano, Giovanni Randon, Elisabetta Zulato, et al.. (2015). Metformin: a modulator of bevacizumab activity in cancer? A case report. Cancer Biology & Therapy. 16(2). 210–214. 10 indexed citations
16.
Fiorentini, Giammaria, Camillo Aliberti, Donatella Sarti, et al.. (2015). DEBIRI and cetuximab (DEBIRITUX) as a secondline treatment for unresectable colorectal liver metastases (UCLM): results of a phase II trial exploring a new sequence. Annals of Oncology. 26. vi43–vi43. 1 indexed citations
17.
Fiorentini, Giammaria, Camillo Aliberti, Donatella Sarti, et al.. (2015). Locoregional therapy and systemic cetuximab to treat colorectal liver metastases. World Journal of Gastrointestinal Oncology. 7(6). 47–47. 18 indexed citations
18.
Valpione, Sara, Marco Zoccarato, Raffaele Parrozzani, et al.. (2013). Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma. Journal of the Neurological Sciences. 335(1-2). 210–212. 11 indexed citations
19.
Aliberti, Camillo, et al.. (2009). Onset of Male Gynaecomastia in a Patient Treated with Sunitinib for Metastatic Renal Cell Carcinoma. Clinical Drug Investigation. 29(7). 487–490. 20 indexed citations
20.
Aliberti, Camillo, Giorgio Benea, Massimo Tilli, & Giammaria Fiorentini. (2008). Chemoembolization (TACE) of Unresectable Intrahepatic Cholangiocarcinoma with Slow-Release Doxorubicin-Eluting Beads: Preliminary Results. CardioVascular and Interventional Radiology. 31(5). 883–888. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026